Graviton Bioscience logo — Curing Disease through Restored Homeostasis

Graviton Bioscience

Curing Disease through Restored Homeostasis

Founded 2023 United States New York, United States 32 employees Private Equity Total: $64.82M Biotechnology, Health and Wellness

General Information

Company Name Graviton Bioscience
Founded Year 2023
Location United States New York, United States +1
Founders / Decision Makers
Team member
Employees 32
Industries Biotechnology, Health and Wellness
Funding Stage Private Equity
Social

Get notified when Graviton Bioscience moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Graviton Bioscience

Graviton Bioscience is a biotechnology startup that aims to cure diseases through restored homeostasis. Founded in 2023 and headquartered in the United States, their focus lies in developing therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), in addition to other therapeutic compounds. Their recent achievement includes securing a $25.00M corporate round investment on 01 February 2024, with Sanofi being the lead investor. This latest investment not only validates the potential of Graviton Bioscience but also paves the way for further advancements in their quest to revolutionize disease treatment through innovative biotechnological approaches. With their pioneering research and strong investor backing, Graviton Bioscience is poised to make significant strides in the biotechnology landscape, offering promising prospects for potential venture capital involvement.

Taxonomy: clinical-stage, drug discovery, CNS disorders, autoimmune disorders, fibrotic disorders, ROCK2 inhibition, therapeutic compounds, homeostasis restoration, disease treatment, pharmaceuticals

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round •••••• 2
Investor
•••• ••••
02 Jan 2024
Venture Round •••••• 1
Investor
20 Dec 2022

Graviton Bioscience Alternatives & Competitors

Graviton Bioscience vs

Pioneering neuroscience solutions with breakthrough therapies for neurological disorders, including...

Series B
2 employees
Biotechnology, Health Care
Graviton Bioscience vs

Now Rho Impact https://www.linkedin.com/company/rho-impact / https://rhoimpact.com

Seed
4 employees
AI, IT
Graviton Bioscience vs

Rho-Can is a Tool and Die shop. We design, manufacture, fabricate almost anything you need

27 employees
Industrial
Also compare with: Graviton Bioscience vs RHO Systems RHO Systems

FAQ About Graviton Bioscience

Curing Disease through Restored Homeostasis
Graviton Bioscience was founded in 2023.
Graviton Bioscience is headquartered in New York, United States.
Graviton Bioscience operates in the following industries: Biotechnology, Health and Wellness.
Graviton Bioscience has approximately 32 employees.
Graviton Bioscience has completed 2 funding rounds, raising a total of $64.82M. The latest funding stage is Private Equity.
Top alternatives and competitors to Graviton Bioscience include BioAxone Therapeutic, Inc., Rho AI (now Rho Impact), Rho-Can Machine & Tool Company Ltd, Envirogen Group Itali spa (Fluxa Filtri spa), RHO Systems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Graviton Bioscience and BioAxone Therapeutic, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Graviton Bioscience and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes